Related Experiment Video
Updated: Nov 16, 2025

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Intussusception caused by small intestine metastasis of malignant pleural mesothelioma: a case report
Michinori Hamaoka1, Masataka Nakagawa1, Hideki Nakahara1
1Department of Gastroenterological Surgery, Hiroshima Prefectural Hospital, Hiroshima 734-8530, Japan.
Abstract:
Malignant pleural mesothelioma (MPM) is an aggressive form of malignant tumor that originates in the pleural mesothelioma and presents as a local disease in the affected hemithorax. Small intestine metastasis is a rare complication. Herein, the case of a patient with jejunal intussusception caused by small intestine metastasis of MPM has been reported. A 72-year-old man with MPM was admitted to our hospital for abdominal pain. Computed tomography revealed small intestine intussusception. An emergency surgery was performed, and the tumor and intussusception were located in the upper jejunum. Histopathological examination of the resected jejunum revealed that the tumor was a small intestinal metastasis of the MPM from the chest wall. This case showed that MPM may metastasize to the small intestine, and metastatic tumors may cause intussusception.
Insights
Malignant pleural mesothelioma (MPM) rarely spreads to the small intestine. This case highlights how MPM metastasis can cause jejunal intussusception, a serious intestinal obstruction.
Area of Science:
- Oncology
- Gastroenterology
- Surgical Pathology
Background:
- Malignant pleural mesothelioma (MPM) is an aggressive thoracic malignancy.
- Small intestine metastasis from MPM is exceptionally rare.
- Intussusception is a condition where one part of the intestine slides into another.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

